Meeting Coverage

Fixed duration ibrutinib plus venetoclax benefited survival outcomes in patients with high-risk CLL/SLL over more than 5 years of follow-up.

Investigators examined the changes in mortality rates due to COVID-19, influenza, and pneumonia in patients with MM.

The treatment landscape for non-small cell lung cancer has significantly evolved with the advent of targeted therapies.

The following is a summary of “Association between social determinants of health and time to...

The following is a summary of “Association between financial fragility and treatment patterns in...

The following is a summary of “Access to palliative care in patients with multiple myeloma in the...

The following is a summary of “Patterns and predictors of electronically measured oral anticancer...

The following is a summary of “Real-world outcomes (RWO) with tandem transplantation in patients...

The following is a summary of “J-TAIL-2: A prospective observational study of atezolizumab (atezo)...

The following is a summary of “Assessing quality of care in early-stage resected stage non-small...

ASCO Voices has become an anticipated staple of the conference. It is an opportunity for physicians to share their platform and experiences on a scale unlike any other.

ASCO Voices has become an anticipated staple of the conference. It is an opportunity for physicians to share their platform and experiences on a scale unlike any other.

ASCO Voices has become an anticipated staple of the conference. It is an opportunity for physicians to share their platform and experiences on a scale unlike any other.

Are you traveling to Chicago for ASCO? Here’s some places to visit.

Are you traveling to Chicago for ASCO? Here’s some places to visit.

Are you traveling to Chicago for ASCO? Here’s some places to visit.

What ASCO ancillary event are you excited to attend?

What ASCO ancillary event are you excited to attend?

What ASCO ancillary event are you excited to attend?

The Industry Expert Theater offers hour-long, nonaccredited educational presentations by industry leaders. These sessions will cover the latest advancements in oncology practices, products, services, and technologies.